Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered 3D-Lattice Microneedle Array Patches for Enhanced Nanovaccine Delivery to Dendritic Cells in Cancer Immunotherapy.

ACS nano·2026
Same author

Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics.

Nature biotechnology·2026
Same author

Type I IFNs Decrease SARS-CoV-2 Replication in Human Cardiomyocytes and Increase Cytokine Production in Macrophages.

Journal of clinical immunology·2025
Same author

Scalable single-cell total RNA-seq reveals non-coding programs in immunity, infection, and brain development.

Research square·2025
Same author

PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2.

Nature communications·2025
Same author

MAVS signaling of long-lived brain-resident myeloid cells is needed during viral encephalitis to adjust the transcriptome of CNS infiltrating CD8<sup>+</sup> T cells.

Journal of neuroinflammation·2025

Related Experiment Video

Updated: Jun 3, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Preformulated, Shelf-Stable, Dendritic Cell-Targeting Nanogel mRNA Vaccine Delivery Platform.

Amy E Laturski1, Verónica Durán2,3, Bruce T Schaar4

  • 1Department of Chemistry, Stanford University, Stanford, California 94305, United States.

Bioconjugate Chemistry
|June 1, 2026
PubMed
Summary

Scientists developed a new mRNA delivery platform using nanogels called TRAINs. This adaptable technology allows for rapid vaccine development and targeted delivery, overcoming limitations of current mRNA vaccines.

More Related Videos

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jun 3, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded Poly(Beta Aminoesters) Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Vaccinology

Background:

  • Current mRNA vaccine platforms face challenges in manufacturing, cold-chain requirements, and precise delivery.
  • These limitations hinder global accessibility and targeted therapeutic applications of mRNA technology.

Purpose of the Study:

  • To develop a modular and adaptable mRNA delivery platform.
  • To overcome the limitations of existing mRNA vaccine technologies through innovative nanogel design.

Main Methods:

  • Fabrication of targeted reductively cleavable acrylate-based inverse microemulsion nanogels (TRAINs) using inverse microemulsion technology.
  • Adsorption-based mRNA loading and postsynthetic surface functionalization for ligand-directed targeting.
  • In vitro studies in HEK293T cells and in vivo studies in BALB/c mice and human peripheral blood mononuclear cells.

Main Results:

  • TRAINs demonstrated efficient mRNA association, cellular uptake, and translation.
  • CD206-targeted TRAINs selectively delivered mRNA to antigen-presenting cells (APCs).
  • Sustained, localized protein expression was observed in mice, with preferential delivery to myeloid APCs in human cells.

Conclusions:

  • TRAINs represent a versatile, surface-customizable mRNA delivery system.
  • The platform enables rapid adaptation for emerging pathogens and targeted vaccination strategies, particularly for APCs.
  • This technology holds promise for enhanced pandemic preparedness and precise therapeutic applications.